1. Home
  2. HG vs LMAT Comparison

HG vs LMAT Comparison

Compare HG & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Insurance Group Ltd. Class B

HG

Hamilton Insurance Group Ltd. Class B

HOLD

Current Price

$34.96

Market Cap

2.4B

Sector

N/A

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$81.86

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HG
LMAT
Founded
2013
1983
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
HG
LMAT
Price
$34.96
$81.86
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$32.00
$105.80
AVG Volume (30 Days)
387.1K
395.8K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
6.26%
0.93%
EPS Growth
51.23
30.57
EPS
2.73
1.42
Revenue
$2,905,524,000.00
$249,602,000.00
Revenue This Year
$1.80
$14.21
Revenue Next Year
$12.52
$8.88
P/E Ratio
$12.74
$57.97
Revenue Growth
24.70
13.53
52 Week Low
$22.66
$78.65
52 Week High
$37.31
$118.01

Technical Indicators

Market Signals
Indicator
HG
LMAT
Relative Strength Index (RSI) 50.02 36.55
Support Level $28.11 $80.96
Resistance Level $37.31 $89.00
Average True Range (ATR) 1.00 3.06
MACD -0.18 -0.29
Stochastic Oscillator 36.94 11.91

Price Performance

Historical Comparison
HG
LMAT

About HG Hamilton Insurance Group Ltd. Class B

Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select, and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: